Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.9794
-0.0206 (-2.06%)
Oct 26, 2026, 1:27 PM EDT - Market open
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of $247.7 million as of October 26, 2026. It is the 19,214th most valuable company in the world and the 3,354th biggest in the United States. Its market cap has decreased by 36.19% in one year.
Market Cap
247.70M
Enterprise Value
199.17M
1-Year Change
-36.19%
Global Rank
Country Rank
#3,354 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $247.70M, an increase of 68.04%. That is a compound annual growth rate of 1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 247.70M | -35.60% |
| Dec 31, 2025 | 384.60M | 305.70% |
| Dec 31, 2024 | 94.80M | -50.29% |
| Dec 29, 2023 | 190.70M | -4.12% |
| Dec 30, 2022 | 198.90M | -51.84% |
| Dec 31, 2021 | 413.00M | 56.44% |
| Dec 31, 2020 | 264.00M | 98.05% |
| Dec 31, 2019 | 133.30M | 15.01% |
| Dec 31, 2018 | 115.90M | -57.51% |
| Dec 29, 2017 | 272.80M | -26.90% |
| Dec 30, 2016 | 373.20M | -4.09% |
| Dec 31, 2015 | 389.10M | 25.52% |
| Dec 31, 2014 | 310.00M | 28.15% |
| Dec 31, 2013 | 241.90M | 51.38% |
| Dec 31, 2012 | 159.80M | -45.26% |
| Dec 30, 2011 | 291.90M | -26.38% |
| Dec 31, 2010 | 396.50M | 181.41% |
| Dec 31, 2009 | 140.90M | 234.68% |
| Dec 31, 2008 | 42.10M | 347.87% |
| Dec 31, 2007 | 9.40M | 54.10% |
| Dec 29, 2006 | 6.10M | 10.91% |
| Dec 30, 2005 | 5.50M | -79.55% |
| Dec 31, 2004 | 26.90M | 43.09% |
| Dec 31, 2003 | 18.80M | -10.05% |
| Dec 31, 2002 | 20.90M | -60.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 259.22M |
| SAB Biotherapeutics | 258.40M |
| Q32 Bio | 257.51M |
| Fate Therapeutics | 252.82M |
| Abeona Therapeutics | 251.61M |
| Rocket Pharmaceuticals | 251.38M |
| Ocugen | 250.84M |
| Cabaletta Bio | 249.23M |